New York & Company, Inc. (NYSE:NWY), together with its subsidiaries, operates as a specialty retailer of women’s apparel in the United States. New York & Company offers casual and wear-to-work apparel and accessories, including pants, jackets, knit tops, blouses, sweaters, denim, t-shirts, activewear, handbags, and jewelry.

Fresenius Kabi Pharmaceuticals (NASDAQ:APCVZ) previously reported that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately. Topotecan for Injection is therapeutically equivalent to the reference-listed drug Hycamtin®, which is currently marketed by the innovator GlaxoSmithKline, plc.